Search results
What drinking beer really does to your body – and the healthiest options for a pint
The Telegraph via Yahoo News· 11 hours agoA refreshing pint on a warm day is part of British culture. A pint after work on a Friday is, as TV...
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
Zacks via Yahoo Finance· 1 day agoLast year, positive data from a late-stage study evaluating Novo Nordisk’s new diabetes drug,...
DexCom's (DXCM) G7 CGM System Now Connects to Apple Watch
Zacks via Yahoo Finance· 2 days agoThe alert settings on the system have also been improved. Industry Prospects Per a report by...
CSPC Pharma Weighs Up Diet Drug For Bigger Bottom Line - CSPC Pharma Gr (OTC:CSPCY), Novo Nordisk...
Benzinga· 3 days agoIt can already fill pharmacy shelves with a wide range of approved drugs for the treatment of...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 1 day agoThe company is the de facto leader of the cystic fibrosis drug market. In the first quarter, sales...
Is This Trend a Threat to Eli Lilly's Weight Loss Drug Dominance?
Motley Fool via Yahoo Finance· 2 days agoMounjaro, which won approval back in 2022, is officially approved for type 2 diabetes, but doctors...
Ozempic and Wegovy Are Fueling Novo Nordisk's Business, but Something Else May Be an Even Bigger...
The Motley Fool via AOL· 6 days agoThis has forced Novo Nordisk to take some aggressive and costly measures. Earlier this year, the...
New report reveals concerning levels of contaminant found in products of several popular olive oil...
The Cool Down via Yahoo News· 3 days agoWhy are phthalates in olive oil brands concerning? Finding even trace amounts of phthalates is...
How to lose weight fast – and safely
The Telegraph via Yahoo News· 5 days agoWhether it’s to slim down for a holiday or a special occasion, or because our health is at risk, the idea of following NHS advice to go slowly when we...
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030,...
Business Insider· 7 days agoThe anti-obesity drug market will be worth $130 billion by 2030, Goldman Sachs analysts said in a...